Keyphrases
Liver Transplantation
63%
T Cell Bispecific
55%
Patients with Heart Failure
55%
Digoxin
55%
Heart Failure with Preserved Ejection Fraction (HFpEF)
55%
Cardiovascular Testing
55%
Chimeric Antigen Receptor T-cell Therapy
55%
Cardiotoxicity
55%
Chimeric Antigen Receptor T Cells (CAR-T)
55%
Adverse Cardiac Events
55%
Kidney Transplant Recipients
55%
Myocardial Injury after Noncardiac Surgery
55%
Operative
55%
T Cells
55%
Pretransplant
55%
Periprocedural Myocardial Infarction
55%
Liver Transplant Recipients
55%
Bispecific Antibody
44%
Cardiovascular Effects
33%
Antibody Therapy
33%
Confidence Interval
32%
Coronary Artery Disease
27%
Transthoracic Echocardiography
27%
Cardiovascular Mortality
25%
Hazard Ratio
24%
Heart Failure
23%
Cytokine Release Syndrome
22%
Novel Therapies
22%
Cardiovascular Events
22%
Transplant Center
21%
Revascularization
21%
Myocardial Infarction
19%
Matched Cohort
18%
Transplantation
15%
Baseline Characteristics
14%
Optimal Testing
13%
Electronic Medical Records
13%
Cardiac Testing
13%
End-stage Liver Disease
13%
Demographic Data
13%
ST-elevation Myocardial Infarction (STEMI)
13%
Exercise Electrocardiogram
13%
Risk Factors
13%
Myocardial Perfusion Imaging
13%
Coronary Computed Tomography Angiography
13%
Multiorgan Transplantation
13%
Testing Practices
13%
Clinical Outcomes
13%
January 2015
13%
Clinical Data
13%
Medicine and Dentistry
Cardiovascular System
100%
Transplantation
62%
Liver Graft
62%
Liver Transplantation
62%
T Lymphocyte Antibody
55%
Heart Muscle Injury
55%
Kidney Graft
55%
Chimeric Antigen Receptor T-Cell Immunotherapy
55%
Cardiotoxicity
55%
Chimeric Antigen Receptor T-Cell
55%
Noncardiac Surgery
48%
Major Adverse Cardiac Event
48%
Bispecific Antibody
44%
Antibody Therapy
33%
Cytokine Release Syndrome
22%
Cardiovascular Effect
22%
Myocardial Infarction
18%
Prospective Study
18%
Apoplexy
18%
Congestive Heart Failure
18%
Revascularization
13%
Troponin
13%
Coronary Artery Disease
13%
Echocardiography
13%
Kidney Transplantation
13%
Cohort Analysis
11%
Respiratory Failure
11%
Lung Cancer
11%
Hematologic Malignancy
11%
Side Effect
11%
Hypotension
11%
Myocardial Disease
11%
Melanoma
11%
Cardiac Testing
6%
Cardiac Catheterization
6%
ST Segment Elevation Myocardial Infarction
6%
Patient History of Liver Transplantation
6%
Patient Population
6%
Myocardial Perfusion Imaging
6%
Organ Transplantation
6%
Hazard Ratio
6%
Exercise Electrocardiography
6%
Computer Assisted Tomography
6%
Cardiovascular Disease
6%
Electronic Patient Record
6%
End Stage Liver Disease
6%
Diabetes
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
55%
Heart Failure with Reduced Ejection Fraction
55%
Digoxin
55%
Cardiotoxicity
55%
T Lymphocyte Antibody
55%
Bispecific Antibody
37%
Congestive Heart Failure
27%
Cytokine Release Syndrome
18%
Prospective Study
9%
Lung Cancer
9%
Side Effect
9%
Hematologic Malignancy
9%
Hypotension
9%
Cohort Study
9%
Respiratory Failure
9%
Melanoma
9%
Heart Infarction
9%
Cerebrovascular Accident
9%
Myocardial Disease
9%
All Cause Mortality
6%
Kidney Failure
6%